Stem Hldgs Stock Price, News & Analysis
Company Description
Stem Hldgs (OTC Link: STMH) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $667.0.
STMH stock has declined 100.0% over the past year. Shares last traded at $0.0000.
On a trailing twelve-month basis, Stem Hldgs reported net income of -$19.0M and diluted earnings per share of $-7.67.
This page provides a comprehensive overview of STMH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Stem Hldgs (STMH) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $667.0, STMH is classified as a micro-cap stock with approximately 6.7M shares outstanding.
Latest News
Stem Hldgs has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 7 with negative movement. Key topics include stock split. View all STMH news →
SEC Filings
Financial Highlights
operating income reached -$3.7M, and net income was -$19.0M. Diluted earnings per share stood at $-7.67. The company generated -$1.2M in operating cash flow. With a current ratio of 0.95, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
STMH Company Profile & Sector Positioning
Stem Hldgs (STMH) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing STMH often look at related companies in the same sector, including Clever Leaves Holdings Inc (CLVR), Juva Life (JUVAF), Halo Collective Inc (HCANF), Fluent Corp (CNTMF), and TREES CORP (CANN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate STMH's relative position within its industry.